These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 25860248

  • 1. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.
    Sonoda Y, Gohda T, Suzuki Y, Omote K, Ishizaka M, Matsuoka J, Tomino Y.
    PLoS One; 2015; 10(4):e0122212. PubMed ID: 25860248
    [Abstract] [Full Text] [Related]

  • 2. Circulating Tumor Necrosis Factor α Receptors Predict the Outcomes of Human IgA Nephropathy: A Prospective Cohort Study.
    Oh YJ, An JN, Kim CT, Yang SH, Lee H, Kim DK, Joo KW, Paik JH, Kang SW, Park JT, Lim CS, Kim YS, Lee JP.
    PLoS One; 2015; 10(7):e0132826. PubMed ID: 26177311
    [Abstract] [Full Text] [Related]

  • 3. Effect of tonsillectomy with steroid pulse therapy on circulating tumor necrosis factor receptors 1 and 2 in IgA nephropathy.
    Murakoshi M, Gohda T, Sonoda Y, Suzuki H, Tomino Y, Horikoshi S, Suzuki Y.
    Clin Exp Nephrol; 2017 Dec; 21(6):1068-1074. PubMed ID: 28389814
    [Abstract] [Full Text] [Related]

  • 4. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S, Park J, Kim J, Jang HR, Kwon GY, Huh W, Kim YG, Kim DJ, Oh HY, Lee JE.
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [Abstract] [Full Text] [Related]

  • 5. Fractional excretion of tumor necrosis factor receptor 1 and 2 in patients with type 2 diabetes and normal renal function.
    Gohda T, Kamei N, Kubota M, Tanaka K, Yamashita Y, Sakuma H, Kishida C, Adachi E, Koshida T, Murakoshi M, Hagiwara S, Funabiki K, Ueda S, Suzuki Y.
    J Diabetes Investig; 2021 Mar; 12(3):382-389. PubMed ID: 32643269
    [Abstract] [Full Text] [Related]

  • 6. Serum levels of tumor necrosis factor alpha in patients with IgA nephropathy are closely associated with disease severity.
    Li G, Wu W, Zhang X, Huang Y, Wen Y, Li X, Gao R.
    BMC Nephrol; 2018 Nov 14; 19(1):326. PubMed ID: 30428849
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.
    Zittema D, van den Brand JA, Bakker SJ, Wetzels JF, Gansevoort RT.
    Nephrol Dial Transplant; 2017 Jan 01; 32(suppl_1):i146-i153. PubMed ID: 28057871
    [Abstract] [Full Text] [Related]

  • 12. Renal expression of intercellular adhesion molecule-1 in immunoglobulin A nephropathy: tubulointerstitial injury and prognosis.
    Arrizabalaga P, Solé M, Abellana R, Ascaso C, Cardesa A.
    Virchows Arch; 2001 Jul 01; 439(1):27-34. PubMed ID: 11499837
    [Abstract] [Full Text] [Related]

  • 13. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
    Chai L, Cai K, Wang K, Luo Q.
    J Clin Lab Anal; 2021 Jun 01; 35(6):e23774. PubMed ID: 33951240
    [Abstract] [Full Text] [Related]

  • 14. Role of tubulointerstitial plasmin in the progression of IgA nephropathy.
    Uchida T, Oda T, Takechi H, Matsubara H, Watanabe A, Yamamoto K, Oshima N, Sakurai Y, Kono T, Shimazaki H, Tamai S, Kumagai H.
    J Nephrol; 2016 Feb 01; 29(1):53-62. PubMed ID: 25971850
    [Abstract] [Full Text] [Related]

  • 15. Correlation analysis between expression of histone deacetylase 6 and clinical parameters in IgA nephropathy patients.
    Hu Y, Shang M, Shi Y, Tao M, Yuan W, Tang L, Ma X, Cui B, Chen H, Zhou X, Zhuang S, Liu N.
    Ren Fail; 2021 Dec 01; 43(1):684-697. PubMed ID: 33896334
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.